Treatment-Related Adverse Events in Advanced Urothelial Carcinoma

Target Audience
This activity is designed to meet the educational needs of physicians and other healthcare professionals involved in the care of urothelial carcinoma.

Program Overview
This interactive case-based activity requires clinicians to make real-world decisions as they optimize therapeutic strategies for patients with advanced urothelial carcinoma.

Throughout the activity, practitioners will have the opportunity to immediately implement expert guidance and evaluate performance while addressing challenging questions about the latest clinical data and evidence-based recommendations.

Topics addressed include:

Clinical factors and patient-centered considerations that guide decision-making
Implementing guideline recommendations in real-world settings
Mitigating and early recognition toxicities and side effects
Attributing and managing adverse effects

Learning Objectives
Upon completion of this activity, participants should be better able to:

Discuss the latest clinical evidence and guidance for treating advanced and metastatic urothelial carcinoma, including the clinical utility, safety-efficacy profiles and target patient populations for current and emerging therapies
Individualize disease management decisions for patients with urothelial carcinoma, taking into consideration personal and clinical factors that may influence therapeutic efficacy
Recommend evidence-based tactics for identifying, mitigating and managing treatment-related adverse events in a timely and effective manner